Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma
NCT04558853
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
autologous NK cells
Sponsor
Karolinska University Hospital